IPX203
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for IPX203, covering 2019-11-06 to 2023-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations [Phase 3]